Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibody

Clin Exp Rheumatol. 2009 Sep-Oct;27(5):888-9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Humans
  • Immunologic Factors / therapeutic use*
  • Male
  • Middle Aged
  • Rituximab
  • Still's Disease, Adult-Onset / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab